Market Samachar
STAT
·
GLOBAL
·
Detailed data show Pfizer’s monthly obesity drug continues to show potential - statnews.com
As reported by STAT
Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on STAT ↗
Market Samachar is a news aggregator. This article was originally published by
STAT. Tap the button above to read the full story on their site.
🔥 Hot Now
Top stories across markets in the last hour
-
INDIAN
Patience, allocation & compounding, not social media tips, only reliable path to a ₹100-crore portfolio: Radhika Gupta
Markets-Economic Times
-
COMPANIES
SBI pays Rs 8,813 crore dividend to government for FY26, FM Nirmala Sitharaman receives cheque
Stocks-Markets-Economic Times
-
COMPANIES
Adani Energy Solutions vs Power Grid Corp: Which stock is Jefferies betting on?
Stocks-Markets-Economic Times
-
COMPANIES
Wipro shares plunge over 8%. What’s behind the selloff?
Stocks-Markets-Economic Times
-
COMPANIES
Why market crashed today? Sensex plunges 719 points, Nifty closes below 23,150; 7 factors behind Rs 7 lakh crore sell-off
Stocks-Markets-Economic Times
-
INDIAN
Top Gainers & Losers on June 8: Netweb Tech, Wipro, Reliance Power, Swiggy, SAIL, HPCL among top losers
mint - markets
-
INDIAN
UHM Vacation IPO Day 3: GMP plunges sharply! Here's subscription status, price band and other details
mint - markets
-
INDIAN
Why CG Power may command a premium over ABB India and Siemens
mint - markets
More from Market Samachar